0.449

8.72% 0.036

Hcw Biologics Inc (HCWB)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione

Precedente Chiudi:

$0.413

Aprire:

$0.4006

Volume 24 ore:

364.53K

Relative Volume:

0.04

Capitalizzazione di mercato:

$20.00M

Reddito:

$3.50M

Utile/perdita netta:

$-37.33M

Rapporto P/E:

-0.8635

EPS:

-0.52

Flusso di cassa netto:

$-19.15M

1 W Prestazione:

+25.77%

1M Prestazione:

-52.60%

6M Prestazione:

-55.10%

1 anno Prestazione:

-62.89%

Intervallo 1D:

$0.39

$0.45

Intervallo di 1 settimana:

$0.32

$0.45

Portata 52W:

$0.2761

$2.52

Hcw Biologics Inc Stock (HCWB) Company Profile

Nome

Hcw Biologics Inc

Settore

Healthcare (1176)

Industria

Biotechnology (673)

Telefono

954-842-2024

Indirizzo

2929 N COMMERCE PKWY, MIRAMAR

Dipendente

Cinguettio

Prossima data di guadagno

Ultimi documenti SEC

HCWB's Discussions on Twitter

Confronta HCWB con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
HCWB Hcw Biologics Inc	0.449	20.00M	3.50M	-37.33M	-19.15M	-1.00
VRTX Vertex Pharmaceuticals Inc	397.27	102.31B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	701.85	77.13B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	623.82	37.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	245.44	31.66B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	113.08	27.11B	3.30B	-501.07M	1.03B	-2.1146

Hcw Biologics Inc Borsa (HCWB) Ultime notizie

Nov 25, 2024

HCW Biologics issues 2.55 million shares to Armistice Capital By Investing.com - Investing.com Nigeria

Nov 25, 2024

HCW Biologics issues 2.55 million shares to Armistice Capital - Investing.com India

Nov 25, 2024

Nov 23, 2024

HCW Biologics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 23, 2024

Nov 21, 2024

HCW Biologics takes aim at CD8+ in deal with WY Biotech - The Pharma Letter

Nov 21, 2024

HCW Biologics announces pricing of $6.9M registered direct offering, concurrent private placement - MSN

Nov 21, 2024

U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.13% - MSN

Nov 21, 2024

Nov 20, 2024

HCW Biologics : Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules Form 8 K - Marketscreener.com

Nov 20, 2024

HCW Biologics Expands with New Financial Agreements - TipRanks

Nov 20, 2024

HCW Biologics prices $6.9M registered direct offering at $1.03 per share - Yahoo Finance

Nov 20, 2024

Nov 19, 2024

Why Symbotic Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket - Benzinga

Nov 19, 2024

Spotlight on Undervalued Nasdaq Stocks: HCWB, CRDL, NIVF, SINT, APLMA Must-Watch This Week! - Marketscreener.com

Nov 19, 2024

HCWB stock touches 52-week high at $1.97 amid robust gains - Investing.com Australia

Nov 19, 2024

Nov 18, 2024

HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules - Yahoo Finance

Nov 18, 2024

HCW Biologics Secures $6.9M Above-Market Offering with Warrant Coverage | HCWB Stock News - StockTitan

Nov 18, 2024

HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules - Benzinga

Nov 18, 2024

HCW Biologics Announces Pricing of $6.9 Million Registered - GlobeNewswire

Nov 18, 2024

Aclaris Therapeutics (ACRS): Strategic Alliance with Biosion Ignites 53% Stock Surge - BP Journal

Nov 18, 2024

Sintx Technologies, Inc. (SINT): A Bold Move with Strategic Stock Repurchase Program Boosts Investor Confidence - BP Journal

Nov 18, 2024